| 1997 |
Phox2a is required for development of the locus coeruleus, subset of sympathetic/parasympathetic ganglia, and cranial sensory ganglia (VIIth, IXth, Xth); in sensory ganglia, Phox2a controls noradrenergic traits (dopamine-beta-hydroxylase transient expression) and regulates Ret expression, with loss leading to massive apoptosis of ganglion cells. |
Targeted gene deletion (knockout mice), immunohistochemistry, genetic loss-of-function |
Neuron |
High |
9115735
|
| 1997 |
Phox2a and Phox2b are co-expressed at most autonomic nervous system sites; Phox2b expression in cranial ganglia is lost in Phox2a-deficient mice, indicating positive cross-regulation between the two Phox2 genes. |
Knockout mice analysis, in situ hybridization, immunohistochemistry |
Development |
High |
9374403
|
| 1997 |
Arix/Phox2a interacts synergistically with cAMP/PKA signaling to activate the dopamine beta-hydroxylase (DBH) promoter; neither Arix alone nor cAMP alone effectively stimulates DBH transcription in non-neuronal cells, but together they substantially activate it; CREB, CREM, Fos, and Jun interact with the DB1 regulatory element adjacent to the Arix binding site. |
Transient transfection reporter assays, dominant-negative CREB, EMSA, antisera supershift |
Journal of Biological Chemistry |
High |
9341190
|
| 1998 |
MASH1 controls expression of Phox2a in noradrenergic centers of the brain and peripheral autonomic ganglia; in Mash1-/- mutants, Phox2a expression is abolished or massively altered, placing MASH1 upstream of Phox2a in the noradrenergic differentiation cascade. |
Targeted Mash1 knockout mice, in situ hybridization, immunohistochemistry |
Development |
High |
9435281 9435282
|
| 1998 |
BMP2 induces Phox2a expression in neural crest stem cells; constitutive expression of MASH1 induces Phox2a and c-RET; constitutive Phox2a expression induces c-RET but not pan-neuronal markers, placing Phox2a downstream of MASH1 and upstream of c-RET in autonomic neuronal identity specification. |
Retroviral gain-of-function in neural crest stem cells, loss-of-function in Mash1-/- mice, colony assays |
Development |
High |
9435282
|
| 1998 |
Phox2a (and Phox2b) bind to a homeodomain (HD)-binding site within the DBH promoter domain IV in a noradrenergic cell-specific manner and robustly activate DBH promoter activity in DBH-negative cell lines; neither activates tyrosine hydroxylase transcription, demonstrating selectivity for noradrenergic target genes. |
Transient transfection reporter assays, EMSA, forced expression in DBH-negative cell lines |
Journal of Neurochemistry |
High |
9798905
|
| 1998 |
Phox2a binds at least two sites in the DBH proximal promoter (domain II and within domain IV); synergistic activation of DBH transcription requires cooperation between at least two Phox2a-binding sites plus Sp1 and AP2 sites; four tandem copies of domain II increased minimal DBH promoter activity 100-200 fold in a Phox2a-dependent, cell-specific manner. |
Transient transfection with mutant DBH reporter constructs, EMSA, Southwestern analysis, competition and antibody supershift assays, cotransfection |
Journal of Neuroscience |
High |
9763470
|
| 1999 |
In zebrafish, Phox2a (soulless) is necessary and sufficient for locus coeruleus noradrenergic neuron development; Phox2a can induce Phox2b expression and ectopic NA neurons; its expression in LC progenitors requires FGF8 from the mid/hindbrain boundary and optimal BMP signal concentrations. |
Zebrafish genetic mutant (soulless), ectopic overexpression, epistasis with FGF8/BMP signaling pathways |
Neuron |
High |
10595509
|
| 1999 |
Forced expression of Phox2a does not affect human norepinephrine transporter (hNET) promoter activity in NET-negative cells, in contrast to its robust activation of the DBH promoter, demonstrating that Phox2a selectively regulates DBH but not NET through distinct molecular mechanisms. |
Transient transfection reporter assays, primer extension, 5'-RACE |
Journal of Biological Chemistry |
Medium |
10037744
|
| 2000 |
Arix/Phox2a activates DBH transcription through multiple homeodomain binding sites, all of which are essential for basal and PKA-stimulated transcription; intracellular Arix-Arix interactions occur and contribute to site interdependence; the N-terminal activation domain of Arix interacts with CBP (CREB-binding protein) coactivator to potentiate PKA-dependent transcription; Arix also has a C-terminal repression domain. |
Mammalian one- and two-hybrid systems, transfection reporter assays, domain mutational analysis, protein interaction assays |
Journal of Biological Chemistry |
High |
10644760
|
| 2000 |
Both Arix/Phox2a and NBPhox/Phox2b bind to three sites in the rat DBH promoter, form DNA-independent multimers, and exhibit cooperative binding to the DB1 element; when coexpressed, their transcriptional stimulation is non-additive (~equal to either alone), demonstrating independent but non-redundant mechanisms. |
In vitro DNA binding assays, transfection reporter assays, coexpression experiments |
DNA and Cell Biology |
Medium |
11034547
|
| 2001 |
Phox2b directly binds to a homeodomain recognition site in the 5' regulatory region of the human Phox2a gene (shown by EMSA) and transactivates the Phox2a promoter (shown by cotransfection), providing the first molecular evidence that Phox2b directly regulates Phox2a expression. |
EMSA, cotransfection reporter assays, promoter deletion analysis |
Journal of Neuroscience |
High |
11549713
|
| 2001 |
Three homozygous mutations in PHOX2A (two predicted to disrupt splicing; one altering an amino acid in the brachyury-like domain) cause congenital fibrosis of extraocular muscles type 2 (CFEOM2), confirming PHOX2A as essential for oculomotor (nIII) and trochlear (nIV) cranial nerve nucleus development in humans. |
Human genetic mutation analysis (sequencing of CFEOM2 pedigrees), functional domain mapping |
Nature Genetics |
High |
11600883
|
| 2002 |
Single point mutations in the Phox2a homeodomain abolish transactivation of the DBH promoter in vitro and cause loss of noradrenergic neurons in vivo (zebrafish antisense experiments); Phox2a binds DBH promoter as monomer at PBD1 and as dimer at PBD2/PBD3; mutations in 3-4 (but not 1-2) binding sites abolish DBH activation. |
In vitro transactivation assays with homeodomain point mutants, antisense oligonucleotide injection in zebrafish, EMSA with monomeric/dimeric forms |
Journal of Neurochemistry |
High |
11948255
|
| 2002 |
Arix/Phox2a is constitutively phosphorylated in vivo; PKA pathway activation causes dephosphorylation of Arix, which coincides with increased DNA binding activity and DBH transcriptional activation; phosphatase inhibitors reverse this effect, demonstrating that dephosphorylation is required for PKA-mediated DBH transcription. |
In vivo phosphorylation analysis, DNA binding assays, transcription reporter assays, pharmacological treatments (forskolin, phosphatase inhibitors), amino acid analysis (phosphoserine) |
Journal of Biological Chemistry |
High |
11943777
|
| 2003 |
HAND2 (dHAND) synergistically enhances Phox2a-driven transcription at the DBH promoter; this synergy requires Phox2a homeodomain binding sites but not direct HAND2 DNA binding; HAND2 interaction with CBP is required for synergistic activation; Arix/Phox2a coprecipitates with anti-dHAND antisera confirming direct protein-protein interaction. |
Cotransfection reporter assays, site-directed mutagenesis of promoter elements, co-immunoprecipitation, EMSA |
Journal of Biological Chemistry / Developmental Biology |
High |
14506227 14512028
|
| 2004 |
Loss of Phox2a in mice abolishes A6 (locus coeruleus) noradrenergic neuron development; A6 neurons are connected to the neonatal respiratory network (shown by rabies virus transsynaptic tracing); Phox2a-/- mice exhibit impaired respiratory activity that can be phenocopied by pharmacological blockade of alpha1 adrenoceptors during gestation, establishing a pathway from Phox2a → A6 neurons → noradrenaline → alpha1 adrenoceptor signaling → respiratory rhythm maturation. |
Phox2a-/- mice, rabies virus transsynaptic tracing, pharmacological blockade (prazosin), in vivo/in vitro respiratory recordings |
Journal of Neuroscience |
High |
14749437
|
| 2005 |
The cAMP pathway has dual inputs on Phox2a: it regulates both Phox2a transcription (via CREB-mediated mechanism requiring PKA) and Phox2a activity (via dephosphorylation); PKA inhibition or PP2A-like phosphatase inhibition with okadaic acid suppresses Phox2a dephosphorylation, DNA binding, and DBH reporter expression, establishing that Phox2a dephosphorylation is required for its activation. |
Primary neural crest cultures, dominant-negative CREB, pharmacological inhibitors (H89, okadaic acid), in vitro DNA binding, reporter assays |
Journal of Biological Chemistry |
High |
16204240
|
| 2005 |
The Phox2a promoter contains two CRE half-sites at ~-5.5 kb (conserved in mouse and human) that are occupied by CREB and CBP in vivo; a 170-bp region proximal to these CREs containing E-box and CCAAT sites confers synergistic BMP2+cAMP regulation; CREB directly activates Phox2a transcription via these elements. |
Chromatin immunoprecipitation (ChIP), transient transfection of reporter constructs, histone deacetylase inhibitor treatment |
Journal of Biological Chemistry |
High |
16330553
|
| 2005 |
Arix/Phox2a is phosphorylated by ERK1/2 at two sites within the N-terminal transactivation domain; ERK1/2-mediated phosphorylation inhibits Arix interaction with DBH and NET (but not TH) target genes; MEK1 inhibition reduces Arix phosphorylation and elevates DBH and NET mRNAs in sympathetic neurons. |
In vitro kinase assays, MEK1 inhibitors (UO126, PD98059), chromatin interaction assays, mRNA quantification in sympathetic neurons |
Journal of Neurochemistry |
High |
16156742
|
| 2006 |
Phox2a, activated by cAMP/BMP2 signaling, directly binds homeodomain cis-acting elements in the p27(Kip1) promoter in vivo and induces p27(Kip1) transcription; siRNA silencing of Phox2a suppresses p27(Kip1) transcription and neuronal differentiation; ectopic Phox2a promotes accelerated differentiation and p27(Kip1) transcription only in the presence of cAMP, establishing Phox2a as a coordinator of neural progenitor cell cycle exit and differentiation. |
siRNA knockdown, Tet-off ectopic expression, ChIP, luciferase reporter assays, primary neural crest cells and CAD cell line |
Molecular and Cellular Biology |
High |
16982676
|
| 2007 |
PHOX2A regulates the human alpha3 nicotinic acetylcholine receptor subunit gene (CHRNA3) promoter; PHOX2A assembles on the SacI-NcoI region of the alpha3 promoter (shown by ChIP and DNA pulldown); it does not appear to bind DNA directly (homeodomain dispensable for regulation) but interacts with Sp1 via direct or indirect protein-protein interactions (shown by co-immunoprecipitation), regulating alpha3 transcription through a DNA-independent mechanism. |
Chromatin immunoprecipitation (ChIP), DNA pulldown assay, cotransfection reporter assays, co-immunoprecipitation |
Journal of Biological Chemistry |
High |
17344216
|
| 2007 |
PHOX2A directly transactivates the TLX2 gene; PHOX2A, like PHOX2B, binds TLX2 regulatory sequences (shown by EMSA and ChIP) and activates TLX2 transcription (shown by cotransfection), placing PHOX2A in a cascade leading to intestinal neuronal differentiation. |
Cotransfection reporter assays, EMSA, chromatin immunoprecipitation (ChIP) |
European Journal of Human Genetics |
Medium |
17505528
|
| 2009 |
cAMP-dependent activation of Phox2a involves two sequential phosphorylation events: first, dephosphorylation of Ser206 (identified by mass spectrometry) allows Phox2a to bind DNA and initiate p27(Kip1) transcription; second, PKA phosphorylates Ser153 (after dephosphorylation of Ser202/Ser208), preventing DNA association and terminating transcription—providing a built-in temporal switch within the same cAMP signal. |
Mass spectrometry phosphosite identification, phosphospecific antibodies, serine-to-alanine/aspartate mutants in inducible cell lines, in vitro DNA binding assays |
Molecular and Cellular Biology |
High |
19564421
|
| 2010 |
In chick midbrain, forced expression of PHOX2A drives a complete oculomotor complex (OMC) molecular program including both visceral and somatic motoneuron production, generates ectopic motor nerves that directly innervate extraocular muscle, and directs ectopic neurons to their correct native spatial positions, demonstrating that a single transcription factor can both specify motoneuron cell fates and orchestrate spatially organized nucleogenesis. |
In ovo forced expression (chick electroporation), immunohistochemistry, nerve tracing |
Development |
High |
20215354
|
| 2011 |
Lmx1b regulates Phox2a expression and the sequential specification of ocular motor neurons and red nucleus neurons from progenitors lateral to dopamine neurons in the midbrain; Phox2a expression is lost in Lmx1b mutants, placing Lmx1b upstream of Phox2a in midbrain motor neuron specification. |
Lmx1b conditional knockout mice, in situ hybridization, immunohistochemistry |
Development |
High |
21752929
|
| 2020 |
Most spinal neurons that embryonically express Phox2a innervate nociceptive brain targets (parabrachial nucleus and thalamus); Phox2a plays an essential role in the development of nociceptive relay neurons (anterolateral system neurons), and the molecular identity of Phox2a neurons is conserved in the human fetal spinal cord. |
Phox2a::Cre lineage tracing, retrograde labeling, immunohistochemistry, developmental analysis of birth order/migration |
Cell Reports |
High |
33238113
|
| 2022 |
Deletion of Dcc (netrin-1 receptor) specifically in Phox2a neurons impairs topognosis (rostrocaudal localization of noxious stimuli) and causes defective targeting of cervical and lumbar anterolateral system axons within the thalamus, establishing that DCC-netrin signaling in Phox2a neurons is required for somatotopic map formation. |
Conditional Dcc knockout in Phox2a neurons, anatomical tracing, behavioral assays |
Journal of Neuroscience |
High |
36028316
|
| 2023 |
Prdm12 is required in somatosensory neural precursors to repress Phox2a and Phox2b expression; loss of Prdm12 leads to ectopic Phox2a/Phox2b expression in dorsal root and trigeminal ganglia, suggesting Prdm12 prevents nociceptor precursors from adopting a Phox2-driven visceral neuronal fate. |
Prdm12 knockout mouse model, immunohistochemistry, in situ hybridization, transcriptomic analysis |
iScience |
Medium |
38025786
|
| 2024 |
A PHOX2A variant (p.Trp137Cys) shows reduced or abolished DNA binding in protein binding microarray assays, establishing that Trp137 within the homeodomain is critical for DNA binding activity of PHOX2A. |
Protein binding microarrays, zebrafish G0 CRISPR/Cas9 knockout phenotypic screen |
bioRxiv (preprint)preprint |
Medium |
|
| 2025 |
Phox2a is expressed in LSN Tac1-positive neurons and is downregulated during chloroquine-induced histamine-independent itch; overexpression of Phox2a in LSNTac1 neurons suppresses scratching behavior and reduces sEPSC amplitude without changing frequency, indicating Phox2a modulates histamine-independent itch via presynaptic excitability regulation. |
Chemogenetic activation/inhibition, whole-cell patch-clamp, viral-mediated overexpression, immunohistochemistry, FISH, behavioral assays |
CNS Neuroscience & Therapeutics |
Medium |
41204431
|